Your browser doesn't support javascript.
loading
Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment.
Yang, Yang; Liu, Qilong; Cao, Lei; Sun, Wei; Gu, Xiaowei; Liu, Bin; Xiao, Na; Teng, Fei; Li, Xiaoli; Chen, Meiji; Yu, Weiguang; Lin, Huanyi; Xu, Guixing.
Afiliação
  • Yang Y; Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Department of Medical Oncology, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China.
  • Liu Q; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
  • Cao L; Department of Anaesthesiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
  • Sun W; Department of Anaesthesiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
  • Gu X; Department of Head and Neck Surgery, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China.
  • Liu B; Central Laboratory, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China.
  • Xiao N; Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Department of Medical Oncology, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China.
  • Teng F; Department of Radiotherapy, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China.
  • Li X; Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Department of Medical Oncology, Affiliated Hospital of Hebei University, No. 212, Yuhua Dong Road, Lianchi District, Baoding, 071000, Hebei Province, China. lxl800002@163.com.
  • Chen M; Department of Pediatrics, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
  • Yu W; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
  • Lin H; Department of Urinary Surgery, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China. linhyi2@mail.sysu.edu.cn.
  • Xu G; Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China. xuguix@mail.sysu.edu.cn.
BMC Pulm Med ; 21(1): 172, 2021 May 19.
Article em En | MEDLINE | ID: mdl-34011336
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Afatinib / Compostos de Anilina / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Afatinib / Compostos de Anilina / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article